Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Reolysin (pelareorep)
i
Other names:
reovirus serotype 3, respiratory enteric orphan virus, PO-BB0209, RT3D, AN1004, AN 1004, AN-1004, POBB0209, POBB 0209, PO BB0209
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Adlai Nortye, Andrus Reo, Oncolytics
Drug class:
Apoptosis stimulant
Related drugs:
‹
lurbinectedin (11)
arsenic trioxide (6)
STA-4783 (5)
omacetaxine mepesuccinate (4)
GZ17-6.02 (3)
quaratusugene ozeplasmid (3)
BAL101553 (3)
teserpaturev (1)
IT-141 (1)
Alpha1H (1)
NEO100 (1)
ABI-1968 topical cream (0)
APTO-253 (0)
BP-C1 (0)
BXQ-350 (0)
CM-728 (0)
IL-17E (0)
autologous γδ T lymphocytes (0)
KLTi (0)
MT-3724 (0)
84AA-API 14AA (0)
PVT-1 (0)
SVV-001 (0)
alpha-tocopheroloxyacetic acid (0)
darinaparsin (0)
AFP-464 (0)
elemene injection (0)
BAY1862864 (0)
BS-HH-002.SA (0)
PT-112 (0)
K-333 (0)
piceatannol (0)
AP1903 (0)
PRX302 (0)
lurbinectedin (11)
arsenic trioxide (6)
STA-4783 (5)
omacetaxine mepesuccinate (4)
GZ17-6.02 (3)
quaratusugene ozeplasmid (3)
BAL101553 (3)
teserpaturev (1)
IT-141 (1)
Alpha1H (1)
NEO100 (1)
ABI-1968 topical cream (0)
APTO-253 (0)
BP-C1 (0)
BXQ-350 (0)
CM-728 (0)
IL-17E (0)
autologous γδ T lymphocytes (0)
KLTi (0)
MT-3724 (0)
84AA-API 14AA (0)
PVT-1 (0)
SVV-001 (0)
alpha-tocopheroloxyacetic acid (0)
darinaparsin (0)
AFP-464 (0)
elemene injection (0)
BAY1862864 (0)
BS-HH-002.SA (0)
PT-112 (0)
K-333 (0)
piceatannol (0)
AP1903 (0)
PRX302 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Pancreatic Ductal Adenocarcinoma
No biomarker
Pancreatic Ductal Adenocarcinoma
atezolizumab + pelareorep
Sensitive: B - Late Trials
atezolizumab + pelareorep
Sensitive
:
B
atezolizumab + pelareorep
Sensitive: B - Late Trials
atezolizumab + pelareorep
Sensitive
:
B
HR positive
HER2 Negative Breast Cancer
HR positive
HER2 Negative Breast Cancer
pelareorep
Sensitive: C3 – Early Trials
pelareorep
Sensitive
:
C3
pelareorep
Sensitive: C3 – Early Trials
pelareorep
Sensitive
:
C3
HR positive
HER2 Negative Breast Cancer
HR positive
HER2 Negative Breast Cancer
paclitaxel + pelareorep
Sensitive: C3 – Early Trials
paclitaxel + pelareorep
Sensitive
:
C3
paclitaxel + pelareorep
Sensitive: C3 – Early Trials
paclitaxel + pelareorep
Sensitive
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
pelareorep
Sensitive: D – Preclinical
pelareorep
Sensitive
:
D
pelareorep
Sensitive: D – Preclinical
pelareorep
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login